• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Odyssey Group Intl Inc (OP: ODYY )

    0.0422 -0.0078 (-15.60%)
    Streaming Delayed Price Updated: 11:08 AM EDT, Jul 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,050
    Open 0.0422
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0500
    Today's Range 0.0422 - 0.0422
    52wk Range 0.0210 - 0.2350
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
    Via ACCESSWIRE
    Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
    Via ACCESSWIRE

    Performance

    YTD
    -61.64%
    -61.64%
    1 Month
    +5.50%
    +5.50%
    3 Month
    +11.05%
    +11.05%
    6 Month
    -51.72%
    -51.72%
    1 Year
    -69.84%
    -69.84%

    More News

    Read More
    Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
    Via ACCESSWIRE
    Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
    Via ACCESSWIRE
    Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
    Via ACCESSWIRE
    Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
    From Oragenics, Inc.
    Via Business Wire
    Odyssey Health Inc. Begins Trading on the OTCQB
    Via ACCESSWIRE
    Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS
    Via ACCESSWIRE
    Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly
    Via ACCESSWIRE
    Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
    Via TheNewswire.com
    Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
    Via News Direct
    Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research
    Via News Direct
    Topics Death
    Exposures Death
    Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023
    Via Investor Brand Network
    Topics Animal Testing
    Exposures Animal Testing
    BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    World Cup 2022 to Feature New Protocol to Respond to Suspected Concussions
    Via Investor Brand Network
    Odyssey Health, Inc. (ODYY) Expands Executive Team of New Subsidiary in Strategic Move to Strengthen Marketing of Concussion, Neurological Therapies
    Via Investor Brand Network
    Surgical Team in Spain Completes First-Ever Intestinal Transplant
    Via Investor Brand Network
    BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Upcoming Annual Meeting of Stockholders
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Study Finds Iron Causes Chronic Heart Failure in Heart Attack Survivors
    Via Investor Brand Network
    New Pharmaceutical Subsidiary Geared to Aid Odyssey Health, Inc. (ODYY) Development of Novel Solutions for Brain Related Medical Treatments
    Via Investor Brand Network
    Experts Concerned That Concussion Protocols Don’t Factor in Women
    Via Investor Brand Network
    BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Expansion of Executive Team
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Pleased with Safety Profile of Its PRV-002 Concussion Treatment
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.